Preparation of N-Z-protected N-methylated amino acids
    23.
    发明授权
    Preparation of N-Z-protected N-methylated amino acids 失效
    制备N-Z保护的N-甲基化氨基酸

    公开(公告)号:US06218572B1

    公开(公告)日:2001-04-17

    申请号:US08737740

    申请日:1996-11-19

    IPC分类号: C07C22718

    CPC分类号: C07C269/06 C07C323/59

    摘要: A process for preparing N-protected N-alkylated amino acids of the formula I: in which the substituents have the meanings stated in the description, comprises mixing a compound of the formula II with a solution of potassium tert-butanolate in a non-protic organic solvent, and subsequently adding a C1-2-alkyl halide.

    摘要翻译: 制备式I的N-保护的N-烷基化氨基酸的方法:其中取代基具有说明书中所述的含义,包括将式II化合物与非质子有机物中的叔丁醇钾溶液 溶剂,然后加入C 1-2烷基卤化物。

    Derivatives of polymers for permanent modification of hydrophobic polymers
    26.
    发明授权
    Derivatives of polymers for permanent modification of hydrophobic polymers 失效
    用于永久改性疏水聚合物的聚合物衍生物

    公开(公告)号:US07498386B2

    公开(公告)日:2009-03-03

    申请号:US10530929

    申请日:2003-10-10

    摘要: The present invention relates to polymer compositions comprising at least one hydrophobic polymer and at least one modified polyisobutene; fibers, films, moldings and their further processing products formed from this polymer composition, a process for producing the polymer composition according to the present invention, a process for producing the fibers, films and moldings formed from the polymer composition according to the present invention; dyed polymer compositions comprising at least one hydrophobic polymer, at least one modified polyisobutene and at least one dye; and also fibers, films and moldings formed from the dyed polymer composition according to the present invention and the use of modified polyisobutenes for treating hydrophobic polymers.

    摘要翻译: 本发明涉及包含至少一种疏水性聚合物和至少一种改性聚异丁烯的聚合物组合物; 纤维,薄膜,模制品及其由该聚合物组合物形成的其它加工产品,根据本发明的聚合物组合物的制备方法,由本发明的聚合物组合物形成的纤维的制造方法,薄膜和模制品; 包含至少一种疏水性聚合物,至少一种改性聚异丁烯和至少一种染料的染色聚合物组合物; 以及由根据本发明的染色聚合物组合物形成的纤维,膜和模制品以及改性聚异丁烯用于处理疏水性聚合物的用途。

    Medical Imaging System
    28.
    发明申请
    Medical Imaging System 有权
    医学影像系统

    公开(公告)号:US20070287908A1

    公开(公告)日:2007-12-13

    申请号:US11660801

    申请日:2005-08-16

    IPC分类号: A61B5/055

    CPC分类号: G01R33/3806 A61B5/0555

    摘要: A medical imaging system is provided. The medical imaging system includes a patient positioning table and a patient examination area that is open on at least three sides and accessible from a front side. The patient positioning table is able to be moved into the patient examination area. At least one positioning motor is arranged on a rear side and is separated from the front side by a rear wall element. The at least one positioning motor is operable to adjust the position of a framework. The patient positioning table is disposed on the framework.

    摘要翻译: 提供医学成像系统。 医疗成像系统包括患者定位台和患者检查区域,其在至少三个侧面上是敞开的并且可从前侧进入。 患者定位台能够移动到患者检查区域。 至少一个定位电动机设置在后侧并且通过后壁元件与前侧分离。 所述至少一个定位马达可操作以调整框架的位置。 患者定位台被放置在框架上。

    Arylalkoxythiocoumarins, the preparation thereof and therapeutic
compositions containing these
    30.
    发明授权
    Arylalkoxythiocoumarins, the preparation thereof and therapeutic compositions containing these 失效
    芳基烷氧基硫香环素,其制备方法和含有它们的治疗组合物

    公开(公告)号:US5414006A

    公开(公告)日:1995-05-09

    申请号:US136033

    申请日:1993-10-14

    摘要: Arylalkoxythiocoumarins of the formula ##STR1## where R.sup.1 and R.sup.2 are each, independently of one another, hydrogen, C.sub.1 -C.sub.5 -alkyl, trifluoromethyl, phenyl or halogen, or together are a C.sub.3 -C.sub.5 -alkylene chain, andX is oxygen or sulfur,R.sup.3 is C.sub.1 -C.sub.5 -alkyl or halogen,n is an integer from 0 to 3,R.sup.4 is hydrogen or C.sub.1 -C.sub.4 -alkyl andAr is phenyl, which can be mono- or disubstituted by halogen, C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.1 -C.sub.6 -alkoxy, nitro, cyano, trifluoromethyl or a combination of these substituents or is a heteraromatic ring which has from one to three heteroatoms which can, independently of one another, be N, O or S, and which can be substituted by C.sub.1 -C.sub.6 -alkyl, C.sub.3 -C.sub.7 -cycloalkyl, C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.4 -alkoxy-substituted C.sub.1 -C.sub.6 -alkyl, 5-6-membered oxacycloalkyl, benzyl, C.sub.1 -C.sub.5 -alkoxycarbonyl, perfluoro-C.sub.1 -C.sub.2 -alkyl, phenyl or halogen, are prepared as described and used in therapeutic compositions, especially for treating disorders of the central nervous system.

    摘要翻译: 其中R 1和R 2各自独立地为氢,C 1 -C 5 - 烷基,三氟甲基,苯基或卤素,或一起为C 3 -C 5 - 亚烷基链,并且X为氧或芳基烷氧基, 硫,R3是C1-C5-烷基或卤素,n是0-3的整数,R4是氢或C1-C4-烷基,Ar是可以被卤素单 - 或二取代的苯基,C1-C6-烷基 C 3 -C 7 - 环烷基,C 1 -C 6 - 烷氧基,硝基,氰基,三氟甲基或这些取代基的组合,或者是具有1至3个杂原子的杂芳环,它们可以彼此独立地为N,O或S 可以被C 1 -C 6 - 烷基,C 3 -C 7 - 环烷基,C 1 -C 6 - 烷氧基,C 1 -C 4 - 烷氧基取代的C 1 -C 6 - 烷基,5-6元氧杂环烷基,苄基,C 1 -C 5 - 烷氧基羰基,全氟-C 1 - C 2 - 烷基,苯基或卤素,如治疗组合物中所述和使用,特别是用于治疗中枢神经系统疾病。